Gapeson Pharmaceuticals Private Limited - Board Members
Founded in 2023 and headquartered in Tamil Nadu, India.
2023 Krishnagiri, Tamil Nadu (India) Active
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parthipan Gopalakrishnan Appointed as Managing Director since October 2023 | Managing Director | 26-Oct-2023 | Current |
Dhandapani Swathi Appointed as Director since February 2024 | Director | 01-Feb-2024 | Current |
Murugan Molugan Appointed as Director since October 2023 | Director | 26-Oct-2023 | Current |
Premkumar Appointed as Director since October 2023 | Director | 26-Oct-2023 | Current |
Rasheeda Fayazi Appointed as Director since June 2024 | Director | 01-Jun-2024 | Current |
Subban Ganesan Appointed as Director since February 2024 | Director | 01-Feb-2024 | Current |
Vediappan Rameshkumar Appointed as Director since June 2024 | Director | 01-Jun-2024 | Current |
Venkateshan Balaji Appointed as Director since October 2023 | Director | 26-Oct-2023 | Current |
Premium access Complete director detailsUnlock the complete director and KMP records available for Gapeson Pharmaceuticals Private Limited.
Verified entity values are shown only after access is granted. | |||
People Timeline
Explore the timeline of key personnel in Gapeson Pharmaceuticals Private Limited's leadership journey.
Loading...
Frequently Asked Questions
You can contact Gapeson Pharmaceuticals Private Limited through their registered address at 3/25/8, Gandhi Nagar, Krishnagiri Tamil Nadu, 635001, India, or via their website if available. Social media links are also provided where applicable.
The current directors of Gapeson Pharmaceuticals Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
- Murugan Molugan
- Venkateshan Balaji
- Premkumar
- Dhandapani Swathi
- Subban Ganesan
- Vediappan Rameshkumar
- Rasheeda Fayazi
- PARTHIPAN GOPALAKRISHNAN
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.